Sign in

CIK 0001818382

  • Non-accelerated filer
  • Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851763759
Phone
+1 919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Open-market buy Chief Commercial Officer bought 10,525 shares at $4.72 ($49,678)
  2. 4 Open-market buy Director bought 10,000 shares at $4.83 ($48,300)
  3. 4 Open-market buy President, CEO and Director bought 10,000 shares at $4.83 ($48,300)
  4. 4 Open-market buy Director bought 2,000 shares at $4.83 ($9,660)
  5. 4 Open-market buy CFO and Chief Corp. Deve. Off. bought 2,000 shares at $4.53 ($9,060)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 300,000 shares at an average $9.10 ($2,729,332)
  9. 4 Open-market sale President, CEO and Director sold 300,000 shares at an average $9.10 ($2,729,332)
  10. 4 Open-market buy Director bought 2,500 shares at an average $10.79 ($26,986)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 12 · 235 filings